awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36117718-29ECF8D6-418A-4B13-9989-E99AD2E3BB03
Q36117718-29ECF8D6-418A-4B13-9989-E99AD2E3BB03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36117718-29ECF8D6-418A-4B13-9989-E99AD2E3BB03
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
P2860
Q36117718-29ECF8D6-418A-4B13-9989-E99AD2E3BB03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36117718-29ECF8D6-418A-4B13-9989-E99AD2E3BB03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f71b8aac9d320952bababbf1903117735bd25d2
P2860
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial